{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:24:27Z","timestamp":1791321867105,"version":"4.3.1"},"reference-count":35,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2002,10,17]],"date-time":"2002-10-17T00:00:00Z","timestamp":1034812800000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Photoderm Photoimm Photomed"],"published-print":{"date-parts":[[2002,10]]},"abstract":"<jats:p><jats:bold>Background:<\/jats:bold>Cutaneous T\u00a0Cell Lymphoma (CTCL) is a lymphoma of skin homing usually CD4 \u2003<jats:bold>+<\/jats:bold>\u2003 lymphocytes. There are numerous treatments available both for the early as well as the more advanced stages of the disease. Extracorporeal photochemotherapy is a well\u2010accepted form of treating CTCL. The purpose of our study was to review the experience of treating 20 CTCL patients with extracorporeal photochemotherapy (ECP) at Columbia Presbyterian Medical Center over a seven\u2010year period.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold>The study was conducted as a retrospective chart review of these 20 patients. Summarized demographic characteristics included age at diagnosis, gender, and race. We analyzed the overall response by categorizing patients as having complete response, partial response, stable disease, and progressive disease. We also analysed the predictive value for three factors: peripheral blood CD4\u2003:\u2003CD8 (<jats:bold>&lt;<\/jats:bold>\u200310,\u2003<jats:bold>&gt;<\/jats:bold>\u200310), LDH level (normal, elevated), and erythrodermic status (erythrodermic or nonerythrodermic). The potential prognostic variables were evaluated for linear association with response using Mantel\u2010Haenszel chi\u2010square tests. All statistical tests were two\u2010sided with alpha\u2003<jats:bold>=<\/jats:bold>\u20030.05. The tests were considered to be exploratory and no adjustments for multiple testing were made.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold>There was a significant linear association between response and CD4\u2003:\u2003CD8. Patients with a ratio<jats:bold>&lt;<\/jats:bold>\u200310 were more likely to respond than patients with a ratio<jats:bold>&gt;<\/jats:bold>\u200310. There was a marginally significant linear association between response and LDH level. Patients whose LDH was not elevated at the start of treatment, tended to have a better response to ECP compared to patients with an elevated LDH. There was a suggestion of an association between erythroderma and response although this was not statistically significant. The majority of patients with erythroderma were responders compared to the majority of non\u2010erythrodermic patients who were non\u2010responders. The treatment was well tolerated with minimal side\u2010effects.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold>Apparent predictors of good response to ECP include erythroderma, a relatively low (closer to normal) peripheral CD4\u2003:\u2003CD8, and a normal LDH. This report confirms reports from other institutions indicating that CTCL patients who are erythrodermic with a relatively intact immune system are optimal candidates for ECP.<\/jats:p>","DOI":"10.1034\/j.1600-0781.2002.02762.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T18:35:44Z","timestamp":1047494144000},"page":"232-237","source":"Crossref","is-referenced-by-count":27,"title":["Extracorporeal photochemotherapy \u2013 the Columbia Presbyterian experience"],"prefix":"10.1111","volume":"18","author":[{"given":"Elizabeth","family":"Knobler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Warmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Cocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,10,17]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"725","article-title":"Report of the committee on staging and classification of cutaneous T\u2010cell lymphoma","volume":"63","author":"Bunn P","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(18)30055-8"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30191-8"},{"key":"e_1_2_5_5_2","first-page":"514","article-title":"Bexarotene ligand pharmaceuticals","volume":"1","author":"Hurst RE","year":"2000","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_2_5_6_2","first-page":"649","article-title":"Phase 2 and 3 clinical trial of oral bexarotene (Targretin) caps for the treatment of refractory or persistent early\u2013stage cutaneous T\u2010cell lymphoma","volume":"137","author":"Duvic M","year":"2001","journal-title":"Arch Dermatol"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.2.376"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198702053160603"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(92)70212-X"},{"key":"e_1_2_5_10_2","first-page":"567","article-title":"Extracorporeal photochemotherapy for the treatment of 34 patients with cutaneous T\u2010cell lymphoma (CTCL)","volume":"102","author":"Koh HK","year":"1994","journal-title":"J\u00a0Invest Dermatol"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90683-0"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.8.995-a"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)80226-5"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(05)70422-8"},{"key":"e_1_2_5_15_2","first-page":"629","volume-title":"Yale J\u00a0Biol Med","author":"Heald P","year":"1989"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30272-9"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.1999.tb00077.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.104852"},{"issue":"2","key":"e_1_2_5_19_2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1423-0410.2000.tb00062.x","article-title":"Extracorporeal photochemotherapy \u2013 present and future","volume":"78","author":"Knobler R","year":"2000","journal-title":"Vox Sang"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(18)30062-5"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1054\/blre.2001.0155"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2001.01182.x"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(00)00966-0"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jidsp.5640188"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1073>3.0.CO;2-R"},{"issue":"1","key":"e_1_2_5_26_2","first-page":"16","article-title":"Pathogenesis of cutaneous T\u2010cell lymphoma: implications for the use of recombinant cytokines and photopheresis","volume":"107","author":"Rook AH","year":"1997","journal-title":"Clinic Exp Immunol"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1997.00325.x"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.116345"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12499907"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.1994.tb03340.x"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12329711"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01773.x"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1085-5629(00)80006-1"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70312-6"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40010121.x"},{"key":"e_1_2_5_36_2","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0190-9622(99)70257-4","article-title":"Extracorporeal photochemotherapy does not suppress T\u00a0or B\u00a0cell responses to novel or recall antigens","volume":"41","author":"Suchin K","journal-title":"J\u00a0Am Acad Dermatol 1999"}],"container-title":["Photodermatology, Photoimmunology &amp; Photomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0781.2002.02762.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0781.2002.02762.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0781.2002.02762.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T22:31:19Z","timestamp":1733869879000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0781.2002.02762.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["10.1034\/j.1600-0781.2002.02762.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0781.2002.02762.x","archive":["Portico"],"relation":{},"ISSN":["0905-4383","1600-0781"],"issn-type":[{"value":"0905-4383","type":"print"},{"value":"1600-0781","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}